Beth Ashbridge is a law clerk in the firm’s Litigation Department and a member of its Intellectual Property group. She contributes to the firm's work in patent litigation, patent opinions and due diligence. Dr. Ashbridge joined Goodwin in 2013. Her application to the New York bar is pending; she is working under the supervision of the partners at Goodwin.
In May 2019, Dr. Ashbridge graduated from the J.D. part-time evening program at Fordham University School of Law with honors (Cum Laude), and was extended the Paul Fuller Scholar Designation. Dr Ashbridge has also been granted limited recognition to practice in patent matters before the U.S. Patent and Trademark Office.
Dr. Ashbridge carried out her graduate research in the Chemical Biology program at the Department of Chemistry, University of Cambridge, under the supervision of Sir Professor Shankar Balasubramanian. Dr. Ashbridge worked on several projects involving the in vitro protein expression and reconstitution, and then subsequent single molecule analysis of the human telomerase ribonucleoprotein complex.
Additional projects as part of her Ph.D. research involved the investigation of G-quadruplex formation in proto-oncogenes c-kit and c-myc as a result of torsional strain on double stranded DNA using single molecule optical tweezer technology. Dr. Ashbridge was supported by a Biotechnology and Biological Sciences Research Council grant for her graduate research.
Prior to joining Goodwin, Dr. Ashbridge worked under the guidance of Dr. Malcolm A.S. Moore as a Research Fellow in the Cell Biology Program at Memorial Sloan-Kettering Cancer Center, New York City. Using her cell and molecular biology training, Dr. Ashbridge worked on several projects investigating the importance of the enzyme telomerase in lung and pancreatic cancers, and the role of this complex in double cord blood transplantation.
